TY - JOUR
PY - 2015//
TI - Self-reported aggressiveness during treatment with levetiracetam correlates with depression
JO - Epilepsy and behavior
A1 - Mula, Marco
A1 - Agrawal, Niruj
A1 - Mustafa, Zainab
A1 - Mohanalingham, Krithika
A1 - Cock, Hannah R.
A1 - Lozsadi, Dora A.
A1 - von Oertzen, Tim J.
SP - 64
EP - 67
VL - 45
IS -
N2 - PURPOSE: The purpose of this study was to identify clinical correlates of self-reported aggressiveness (SRA) in patients with epilepsy treated with levetiracetam (LEV) with special reference to the role of depression.
METHODS: A consecutive sample of adult outpatients with epilepsy was assessed with the Neurological Disorder Depression Inventory for Epilepsy, the Adverse Event Profile (AEP), and the Emotional Thermometer.
RESULTS: From a total sample of 163 consecutive patients treated with LEV, SRA at any level (from rarely a problem to always) was associated with a 7-fold increased risk of being depressed (95% CI: 3.0-17.5; p<0.001). Self-reported aggressiveness was reported as "always" a problem by 9.8% of the patients. In these patients, apart from depression, SRA was associated with high AEP total scores (55.1 vs. 39.3; p<0.001) and polytherapy (43.8% vs. 19.8%; p=0.034). Anxiety scores were not elevated (4.9 vs. 3.6; p=0.183).
CONCLUSIONS: Self-reported aggressiveness during treatment with LEV is not an isolated symptom but is associated with depressed mood. Anxiety-mediated mechanisms do not seem to be involved.
Language: en
LA - en SN - 1525-5050 UR - http://dx.doi.org/10.1016/j.yebeh.2015.03.018 ID - ref1 ER -